For research use only. Not for therapeutic Use.
T338C Src-IN-2(Cat No.:I001357)is a selective inhibitor of the Src family kinases, particularly targeting the Src kinase. Src kinases are involved in several cellular processes, including cell proliferation, migration, and survival, and are implicated in various cancers and inflammatory diseases. T338C Src-IN-2 functions by binding to the Src kinase and inhibiting its activity, which can help reduce tumor growth and metastasis in cancer models. It has shown promise in preclinical studies, particularly for cancers with dysregulated Src signaling.
Catalog Number | I001357 |
CAS Number | 1351927-00-8 |
Molecular Formula | C17H18FN5O |
Purity | ≥95% |
Target | Src |
Solubility | 10 mM in DMSO |
Storage | Store at -20°C |
IUPAC Name | 1-[3-[(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)methyl]phenyl]-2-fluoroethanone |
InChI | InChI=1S/C17H18FN5O/c1-10(2)23-17-15(16(19)20-9-21-17)13(22-23)7-11-4-3-5-12(6-11)14(24)8-18/h3-6,9-10H,7-8H2,1-2H3,(H2,19,20,21) |
InChIKey | WEPKWIAJJGCTLW-UHFFFAOYSA-N |
SMILES | CC(C)N1C2=NC=NC(=C2C(=N1)CC3=CC(=CC=C3)C(=O)CF)N |